Betaine promotes chicken growth through modulating gut microbiota and FXR-mediated activation of IGF genes

Betaine is a growth-promoting additive used in both the animal production and microbial fermentation industries. The primary mechanisms by which betaine promotes animal growth are well known through its direct action on the host cells. However, it remains unclear whether betaine exerts its growth-pr...

Full description

Bibliographic Details
Published in:	Poultry Science
Main Authors:	Yan Wang, Shuai Ma, Lei Wu, Ruqian Zhao
Format:	Article
Language:	English
Published:	Elsevier 2025-09-01
Subjects:	Betaine Gut microbiota IGFs Bile acids FXR
Online Access:	http://www.sciencedirect.com/science/article/pii/S0032579125006996

Similar Items

In ovo betaine injection improves breast muscle growth in newly hatched goslings through FXR/IGF-2 pathway
by: Shuai Ma, et al.
Published: (2024-10-01)

Dietary bile acids improve breast muscle growth in chickens through FXR/IGF2 pathway
by: Liang Chen, et al.
Published: (2024-02-01)

Depletion of gut microbiota induces skeletal muscle atrophy by FXR-FGF15/19 signalling
by: Yixuan Qiu, et al.
Published: (2021-01-01)

Weissella cibaria suppresses colitis-associated colorectal cancer by modulating the gut microbiota-bile acid-FXR axis
by: Qiuyao Hao, et al.
Published: (2025-07-01)

HuangQi ChiFeng decoction maintains gut microbiota and bile acid homeostasis through FXR signaling to improve atherosclerosis
by: Jiaqi Fu, et al.
Published: (2023-11-01)

Effects of cholesterol-lowering probiotics on non-alcoholic fatty liver disease in FXR gene knockout mice
by: Minghua Yang, et al.
Published: (2023-07-01)

Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia
by: Hongtao Xu, et al.
Published: (2023-11-01)

Alterations in the gut microbiota and serum metabolomics of spontaneous cholestasis caused by loss of FXR signal in mice
by: Shizhang Wei, et al.
Published: (2023-05-01)

FXR Signaling-Mediated Bile Acid Metabolism Is Critical for Alleviation of Cholesterol Gallstones by Lactobacillus Strains
by: Xin Ye, et al.
Published: (2022-10-01)

Yinchenhao Decoction Mitigates Cholestatic Liver Injury in Mice via Gut Microbiota Regulation and Activation of FXR-FGF15 Pathway
by: Weiwei Li, et al.
Published: (2025-06-01)

Functional changes of the gastric bypass microbiota reactivate thermogenic adipose tissue and systemic glucose control via intestinal FXR-TGR5 crosstalk in diet-induced obesity
by: Julia Münzker, et al.
Published: (2022-06-01)

High-fat diet promotes gestational diabetes mellitus through modulating gut microbiota and bile acid metabolism
by: Lei Yao, et al.
Published: (2025-01-01)

Lactococcus petauri LZys1 modulates gut microbiota, diminishes ileal FXR-FGF15 signaling, and regulates hepatic function
by: Ouyang Li, et al.
Published: (2025-06-01)

Novel Approaches in Glucose and Lipid Metabolism Disorder Therapy: Targeting the Gut Microbiota–Bile Acid Axis
by: Jin Jiang, et al.
Published: (2025-07-01)

A dietary combination of red yeast rice, phytosterol ester and lycopene ameliorates hypercholesterolemia by regulating gut microbiota and activating hepatic FXR-LDLR/ABCG pathway in mice
by: Jingxian Xu, et al.
Published: (2025-08-01)

Dietary bile acid supplementation improves the intestinal health and growth performance of piglets partially through the FXR/AQPs pathway
by: Beibei Zhang, et al.
Published: (2025-05-01)

Ginsenoside Rh4 Improves Hepatic Lipid Metabolism and Inflammation in a Model of NAFLD by Targeting the Gut Liver Axis and Modulating the FXR Signaling Pathway
by: Siming Yang, et al.
Published: (2023-06-01)

Lingguizhugan oral solution alleviates MASLD by regulating bile acids metabolism and the gut microbiota through activating FXR/TGR5 signaling pathways
by: Jiahua Wang, et al.
Published: (2024-08-01)

Bile Acid Physiology
by: Agostino Di Ciaula, et al.
Published: (2017-11-01)

Physiological Role of Bile Acids Modified by the Gut Microbiome
by: Yoshimitsu Kiriyama, et al.
Published: (2021-12-01)

Arisaema cum Bile Mitigate Febrile Seizure in Rats via Inhibition of Neuroinflammation, Regulation of FXR and GABA Signaling Pathway
by: Wu X, et al.
Published: (2025-06-01)

Commentary: Can FXR serve as a potential target for COVID-19 prevention?
by: Juan Pang, et al.
Published: (2023-04-01)

Gut microbiota-related bile acid metabolism-FXR/TGR5 axis impacts the response to anti-α4β7-integrin therapy in humanized mice with colitis
by: Bing Han, et al.
Published: (2023-12-01)

Bile acids affect intestinal barrier function through FXR and TGR5
by: Guangyao Song, et al.
Published: (2025-07-01)

Targeted microbiome metabolomics reveals flaxseed oil supplementation regulated the gut microbiota and farnesoid X receptor pathway in high-fat diet mice
by: Chen Yang, et al.
Published: (2023-11-01)

Dietary Resistant Starch Regulates Bile Acid Metabolism by Modulating the FXR/LRH-1 Signaling Pathway in Broilers
by: Zhenxin Wang, et al.
Published: (2023-11-01)

Diammonium Glycyrrhizinate Ameliorates Obesity Through Modulation of Gut Microbiota-Conjugated BAs-FXR Signaling
by: Yun Li, et al.
Published: (2021-12-01)

Zuojinwan ameliorates depressive-like behavior and gastrointestinal dysfunction in mice by modulating the FXR-bile acid-gut microbiota pathway
by: Dan Qiao, et al.
Published: (2025-06-01)

Isorhamnetin in Quinoa Whole-Grain Flavonoids Intervenes in Non-Alcoholic Fatty Liver Disease by Modulating Bile Acid Metabolism through Regulation of FXR Expression
by: Xiaoqin La, et al.
Published: (2024-09-01)

Gut microbiota-mediated bile acid transformations regulate the transport of aflatoxin B1 from the intestine to the liver in piglets
by: Jiangdi Mao, et al.
Published: (2025-03-01)

Protective effects of Bifidobacterium breve on imiquimod-induced psoriasis in mice through secondary bile acid production and FXR-TLR4/NF-κB pathway
by: Xinqi Chen, et al.
Published: (2024-11-01)

Betaine alleviates obesity-related metabolic disorders in rats: insights from microbiomes, lipidomics, and transcriptomics
by: Xian Wang, et al.
Published: (2025-07-01)

Suppressing FXR promotes antiviral effects of bile acids via enhancing the interferon transcription
by: Xue Liang, et al.
Published: (2024-08-01)

Tailoring FXR Modulators for Intestinal Specificity: Recent Progress and Insights
by: Amanda Morrison, et al.
Published: (2024-04-01)

The regulatory role of bile acid microbiota in the progression of liver cirrhosis
by: Feng Zhu, et al.
Published: (2023-06-01)

Regulating bile acids signaling for NAFLD: molecular insights and novel therapeutic interventions
by: Meilin Wei, et al.
Published: (2024-06-01)

Triclosan exposure causes abnormal bile acid metabolism through IL-1β-NF-κB-Fxr signaling pathway
by: Jing Liu, et al.
Published: (2024-10-01)

Small intestinal taurochenodeoxycholic acid-FXR axis alters local nutrient-sensing glucoregulatory pathways in rats
by: T.M. Zaved Waise, et al.
Published: (2021-02-01)

Activation of gut FXR improves the metabolism of bile acids, intestinal barrier, and microbiota under cholestatic condition caused by GCDCA in mice
by: Xing-Ming Xie, et al.
Published: (2025-04-01)

Non-steroidal FXR agonist cilofexor improves cholestatic liver injury in the Mdr2-/- mouse model of sclerosing cholangitis
by: Claudia D. Fuchs, et al.
Published: (2023-11-01)